학술논문

Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts
Document Type
Article
Source
In Kidney International Reports April 2022 7(4):720-731
Subject
Language
ISSN
2468-0249